Evaluation of biomechanical gait parameters of patients with Cerebral Palsy at three different levels of gait assistance using the CPWalker.


Journal

Journal of neuroengineering and rehabilitation
ISSN: 1743-0003
Titre abrégé: J Neuroeng Rehabil
Pays: England
ID NLM: 101232233

Informations de publication

Date de publication:
28 01 2019
Historique:
received: 01 11 2017
accepted: 16 01 2019
entrez: 30 1 2019
pubmed: 30 1 2019
medline: 6 2 2020
Statut: epublish

Résumé

Cerebral Palsy (CP) is the most common cause of permanent serious physical disability in childhood. Although many platforms have been developed, so far there are still not precise guidelines for the rehabilitation of the population with CP. The CPWalker is a robotic platform for the rehabilitation of children with CP, through which they can start experiencing autonomous locomotion in the rehabilitation environment. It allows the possibility of free movement and includes physical and cognitive interfaces into the therapy. The main objective of this work is to evaluate the effects of the CPWalker-based rehabilitation intervention in children with CP by comparing different gait parameters before, during and after the use of the platform. The evaluation was divided in three stages where the gait parameters and symmetry indexes of eight subjects with CP were evaluated. In the first stage patients walked only with the help they receive normally in daily life. During the second stage they walked with the CPWalker and finally, in the third stage, they repeated their gait without the platform. In all stages they wore an inertial G-Sensor The effect of using the device was analyzed for spatio-temporal parameters, pelvic girdle angles and general gait cycle parameters. Among the eighteen initial parameters, seven presented a statistical significant difference when comparing stage 2 of the intervention with stages 1 and 3. Those changes showed the potential of the CPWalker to improve muscular strength and gait patterns of the patients with CP in the long term and to provide useful information for the design of the future generations of rehabilitation robotic devices.

Sections du résumé

BACKGROUND
Cerebral Palsy (CP) is the most common cause of permanent serious physical disability in childhood. Although many platforms have been developed, so far there are still not precise guidelines for the rehabilitation of the population with CP. The CPWalker is a robotic platform for the rehabilitation of children with CP, through which they can start experiencing autonomous locomotion in the rehabilitation environment. It allows the possibility of free movement and includes physical and cognitive interfaces into the therapy. The main objective of this work is to evaluate the effects of the CPWalker-based rehabilitation intervention in children with CP by comparing different gait parameters before, during and after the use of the platform.
FINDINGS
The evaluation was divided in three stages where the gait parameters and symmetry indexes of eight subjects with CP were evaluated. In the first stage patients walked only with the help they receive normally in daily life. During the second stage they walked with the CPWalker and finally, in the third stage, they repeated their gait without the platform. In all stages they wore an inertial G-Sensor
CONCLUSIONS
The effect of using the device was analyzed for spatio-temporal parameters, pelvic girdle angles and general gait cycle parameters. Among the eighteen initial parameters, seven presented a statistical significant difference when comparing stage 2 of the intervention with stages 1 and 3. Those changes showed the potential of the CPWalker to improve muscular strength and gait patterns of the patients with CP in the long term and to provide useful information for the design of the future generations of rehabilitation robotic devices.

Identifiants

pubmed: 30691493
doi: 10.1186/s12984-019-0485-0
pii: 10.1186/s12984-019-0485-0
pmc: PMC6350321
doi:

Types de publication

Clinical Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

15

Subventions

Organisme : Ministerio de Economía y Competitividad
ID : DPI2012-39133-C03-01
Pays : International

Références

Eur J Phys Rehabil Med. 2012 Mar;48(1):147-53
pubmed: 22543558
J Neuroeng Rehabil. 2011 Dec 13;8:66
pubmed: 22165907
Eur J Paediatr Neurol. 2017 May;21(3):557-564
pubmed: 28188024
Am J Phys Med Rehabil. 2012 Nov;91(11 Suppl 3):S280-9
pubmed: 23080043
J Neuroeng Rehabil. 2016 Nov 14;13(1):98
pubmed: 27842562
Gait Posture. 2017 Feb;52:107-109
pubmed: 27889619
Comput Methods Programs Biomed. 2012 Oct;108(1):129-37
pubmed: 22391334
Phys Med Rehabil Clin N Am. 2009 Aug;20(3):469-91
pubmed: 19643348
J Pediatr Orthop. 2003 May-Jun;23(3):302-7
pubmed: 12724591

Auteurs

Luis Felipe Aycardi (LF)

Department of Biomedical Engineering, Colombian School of Engineering Julio Garavito, Bogotá, Colombia.

Carlos Andrés Cifuentes (CA)

Department of Biomedical Engineering, Colombian School of Engineering Julio Garavito, Bogotá, Colombia.

Marcela Múnera (M)

Department of Biomedical Engineering, Colombian School of Engineering Julio Garavito, Bogotá, Colombia.

Cristina Bayón (C)

Neural and Cognitive Engineering Group, CAR of the Spanish National Research Council (CSIC), Arganda del Rey, Madrid, 28500, Spain.

Oscar Ramírez (O)

Neural and Cognitive Engineering Group, CAR of the Spanish National Research Council (CSIC), Arganda del Rey, Madrid, 28500, Spain.

Sergio Lerma (S)

Niño Jesús Hospital, Madrid, 28009, Spain.

Anselmo Frizera (A)

Department of Electrical Engineering, Federal University of Espirito Santo, ES, Vitória, 29075-910, Brazil.

Eduardo Rocon (E)

Neural and Cognitive Engineering Group, CAR of the Spanish National Research Council (CSIC), Arganda del Rey, Madrid, 28500, Spain. e.rocon@csic.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH